The one study that connects an amino-acid sensor to an organismal ageing phenotype. Loss of Drosophila Sestrin produced triglyceride accumulation, mitochondrial dysfunction, muscle degeneration and cardiac malfunction - all prevented by inhibiting TOR or activating AMPK. Sestrin sits in a negative feedback loop: TOR activity drives Sestrin expression, and Sestrin inhibits TOR back.
Tier C because it is an animal intervention or observation study measuring an organismal outcome (model: Drosophila melanogaster (dSesn loss-of-function)); tier describes study design, not quality -- animal evidence can be rigorous and still sit below direct human data.
| Evidence tier | C Animal in vivo |
| Study type | 4 - Animal Study |
| Model system | Drosophila melanogaster (dSesn loss-of-function) |
| Journal | Science |
| Year | 2010 |
| Peer reviewed | Yes |
| Record last updated | 2026-07-29 |
| Source | DOI 10.1126/science.1182228 · PMID 20203043 |
| Intervention | dSesn loss of function; rapamycin; AMPK activation |
| Target | Sestrin -> AMPK/TOR feedback loop |
| Model | Drosophila |
| Effect | Sestrin loss causes age-related muscle, cardiac and metabolic pathology in flies; rescued by TOR inhibition or AMPK activation |
Barton, O. (2026). Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies — evidence-graded record LEE2010. In Oliver's mTOR Atlas. https://mtor-atlas.org/study/LEE2010/ · Dataset DOI 10.5281/zenodo.22059963
@misc{atlas_LEE2010,
author = {Barton, Oliver},
title = {{Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies} --- evidence-graded record LEE2010},
howpublished = {Oliver's mTOR Atlas},
year = {2026},
url = {https://mtor-atlas.org/study/LEE2010/},
note = {Dataset DOI: 10.5281/zenodo.22059963}
}